Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH)

Clinical trial NCT00633880 · COMPLETED

Trial details

NCT number: NCT00633880
Sponsor: Chelsea Therapeutics
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Symptomatic Neurogenic Orthostatic Hypotension (NOH)Non-diabetic Neuropathy Primary Autonomic Failure Dopamine Beta Hydroxylase Deficiency

Start date: 2008-01-01
Primary completion: 2009-08-01
Enrollment: 181

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.